E

Excellos

31 employees

Excellos is a developer and manufacturer of cell, gene therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunotherapy Development
Product Research
Advanced Materials
TIL Therapies
Allogeneic CAR-T
Health Care
cGMP Manufacturing
Alternative Medicine
Medical
CDMO
Life Science

Date founded

2021

Funding rounds raised

Total raised

$15M

from 1 investors over 1 rounds

E

Excellos raised $15M on January 25, 2022

Investors: Telegraph Hill Partners

FAQ